Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193361 | SCV000247676 | benign | not specified | 2016-01-07 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000193361 | SCV000338529 | likely benign | not specified | 2016-01-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001721254 | SCV000525487 | likely benign | not provided | 2020-12-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000463033 | SCV000563653 | benign | Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002269969 | SCV002553631 | likely benign | Developmental and epileptic encephalopathy, 14 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002269970 | SCV002553632 | likely benign | Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004725047 | SCV005338805 | likely benign | KCNT1-related disorder | 2024-07-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |